NCT05211791

Brief Summary

Thoracotomy operations are known to be painful surgical procedures, so providing effective intraoperative and postoperative analgesia is so important for all anaesthesiologists. Ineffective pain management interferes with deep breathing, coughing, and remobilization resulting in atelectasis and pneumonia. Ultrasound-guided ESP block is a myofascial plane block that provides analgesia for thoracic or abdominal segmental innervation depending on the level of the injection site. Thoracic epidural analgesia (TEA) is considered the gold standard analgesic technique for thoracic surgeries. But the invasiveness of this technique, the rare but serious neurologic complications and the failure rates up to 30% are the disadvantages of epidural analgesia

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

January 10, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 27, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2023

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

1.4 years

First QC Date

January 2, 2022

Last Update Submit

May 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • peri-operative analgesia

    Visual Analogue score (resting and during cough) from 0 (no pain) to 10 (worst pain pain measurement

    up to 48 hours postoperative

Study Arms (3)

Group TEA

ACTIVE COMPARATOR

insertion of Thoracic epidural anesthesia plus GA with lung isolation using suitable size double lumen tube at level T6

Procedure: Thoracic epidural anesthesia

Group ESB

ACTIVE COMPARATOR

U/S guided erector spinae block anesthesia using 15 ml local anesthesia plus GA with lung isolation using a suitable size double-lumen tube

Procedure: erector spinae block

Group PVB

ACTIVE COMPARATOR

U/S guided paravertebral block anesthesia using 15 ml local anesthesia as total volume plus GA with lung isolation using suitable size double lumen tube

Procedure: paravertebral block anesthesia

Interventions

Ultrasound-guided insertion of different analgesic procedures as paravertebral block anesthesia and paravertebral block anesthesia

Group ESB

Ultrasound-guided insertion of different analgesic procedures as paravertebral block anesthesia and paravertebral block anesthesia

Group PVB

insertion of Thoracic epidural catheter for anesthesia analgesia at level of T6

Group TEA

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged between 18 to 70 years old for elective lung resection. with American Society of Anesthesiology physical status (ASA-PS) I-III

You may not qualify if:

  • Total pneumonectomy
  • Hepatic or renal dysfunction.
  • contraindications for epidural anesthesia as Coagulopathy and neurological and spinal deficits.
  • emergency cases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt

Asyut, 0020, Egypt

RECRUITING

MeSH Terms

Conditions

Lung DiseasesAcute Pain

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alaa A Elzohry

    Lecturer of Anesthesia , ICU and pain management

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alaa A Elzohry, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia, ICU and Pain Relief, South Egypt Cancer Institute, Assiut University, Egypt

Study Record Dates

First Submitted

January 2, 2022

First Posted

January 27, 2022

Study Start

January 10, 2022

Primary Completion

June 10, 2023

Study Completion

October 20, 2023

Last Updated

May 9, 2023

Record last verified: 2023-05

Locations